Action pharma a s – product pipeline review – 2012


Published on

2012 || Action Pharma A/S – Product Pipeline Review – 2012

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Action pharma a s – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Action Pharma A/S – Product Pipeline Review – 2012 link of Global Markets Direct Market Direct’s pharmaceuticals report, “Action Pharma A/S - ProductPipeline Review - 2012” provides data on the Action Pharma A/S’s research anddevelopment focus. The report includes information on current developmentalpipeline, complete with latest updates, and features on discontinued and dormantprojects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Action Pharma A/S’s corporate website, SEC filings, investorpresentations and featured press releases, both from Action Pharma A/S andindustry-specific third party sources, put together by Global Markets Direct’s team.Scope- Action Pharma A/S - Brief Action Pharma A/S overview including businessdescription, key information and facts, and its locations and subsidiaries.- Review of current pipeline of Action Pharma A/S human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.
  2. 2. Table of contents:List of Tables 3List of Figures 3Action Pharma A/S Snapshot 4Action Pharma A/S Overview 4Key Information 4Key Facts 4Action Pharma A/S – Research and Development Overview 5Key Therapeutic Areas 5Action Pharma A/S – Pipeline Review 7Pipeline Products by Stage of Development 7Pipeline Products – Monotherapy 8Action Pharma A/S – Pipeline Products Glance 9Action Pharma A/S – Early Stage Pipeline Products 9Pre-Clinical Products/Combination Treatment Modalities 9Action Pharma A/S – Drug Profiles 10AP405 10Product Description 10Mechanism of Action 10R&D Progress 10Action Pharma A/S – Pipeline Analysis 11Action Pharma A/S – Pipeline Products by Therapeutic Class 11Action Pharma A/S – Pipeline Products By Target 12Action Pharma A/S – Pipeline Products by Route of Administration 13Action Pharma A/S – Pipeline Products By Mechanism of Action 14Action Pharma A/S - Dormant Projects 15Action Pharma A/S – Locations And Subsidiaries 16Head Office 16Financial Deals Landscape 17Action Pharma A/S, Deals Summary 17Action Pharma A/S, Pharmaceuticals & Healthcare, Deal Details 18Venture Financing 18List of Figures
  3. 3. List of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview&PubId=&pagenum=1Avir Green Hills Biotechnology AG – Product Pipeline Review – 2012BIOALVO S.A. – Product Pipeline Review – 2012Celator Pharmaceuticals, Inc. – Product Pipeline Review – 2012Cardio3 BioSciences SA – Product Pipeline Review – 2012Cornerstone Pharmaceuticals, Inc. – Product Pipeline Review – 2012Enzon Pharmaceuticals, Inc. – Product Pipeline Review – 2012iCo Therapeutics Inc. – Product Pipeline Review – 2012Neurocrine Biosciences, Inc. – Product Pipeline Review – 2012Mersana Therapeutics, Inc. – Product Pipeline Review – 2012Nexgenix Pharmaceuticals, LLC – Product Pipeline Review – 2012Nuon Therapeutics, Inc. – Product Pipeline Review – 2012
  4. 4. Osmotica Pharmaceutical Corp. – Product Pipeline Review – 2012SymBio Pharmaceuticals Limited – Product Pipeline Review – 2012ProStrakan Group plc – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports onsample@aarkstore.comFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: